View source for Annual pharmaceutical drug sales

===Annual Sales (USD Millions)===
{| class="wikitable sortable"
!width="100"|Medication
!width="100"|Trade name
!width="250"|Primary Indication
!width="100"|Company
!2008<ref name="Genentech 2008 10-K">[http://www.sec.gov/Archives/edgar/data/318771/000031877109000003/form10-k_2008.htm], Genentech 2008 10-K.</ref><ref name="Pfizer 2008 10-K">[http://www.sec.gov/Archives/edgar/data/78003/000119312509040568/dex13.htm], Pfizer 2008 10-K.</ref><ref name="Eli Lilly & Co. 2008 10-K">[http://www.sec.gov/Archives/edgar/data/59478/000095015209001897/c49534e10vk.htm], Eli Lilly & Co. 2008 10-K.</ref><ref name="Allergan 2008 10-K">[http://www.sec.gov/Archives/edgar/data/850693/000119312509040955/d10k.htm], Allergan 2008 10-K.</ref><ref name="Merck 2008 10-K">[http://www.sec.gov/Archives/edgar/data/64978/000095012309003688/y74217e10vk.htm], Merck 2008 10-K.</ref><ref name="Ista Pharmaceuticals 2008 10-K">[http://www.sec.gov/Archives/edgar/data/930553/000119312509034313/d10k.htm], Ista Pharmaceuticals 2008 10-K.</ref>
!2007<ref name="Genentech 2007 10-K">[http://www.sec.gov/Archives/edgar/data/318771/000031877108000004/form10-k_2007.htm], Genentech 2007 10-K.</ref><ref name="Pfizer 2007 10-K">[http://www.sec.gov/Archives/edgar/data/78003/000093041308001360/c52104_ex13.htm], Pfizer 2007 10-K.</ref><ref name="Eli Lilly & Co. 2007 10-K">[http://www.sec.gov/Archives/edgar/data/59478/000095013708003028/c24001e10vk.htm], Eli Lilly & Co. 2007 10-K.</ref><ref name="Allergan 2007 10-K">[http://www.sec.gov/Archives/edgar/data/850693/000089256908000184/a38161e10vk.htm], Allergan 2007 10-K.</ref><ref name="Merck 2007 10-K">[http://www.sec.gov/Archives/edgar/data/64978/000095012308002272/y44547e10vk.htm], Merck 2007 10-K.</ref><ref name="Ista Pharmaceuticals 2007 10-K">[http://www.sec.gov/Archives/edgar/data/930553/000119312508050141/d10k.htm], Ista Pharmaceuticals 2007 10-K.</ref>
!2006<ref name="Genentech 2006 10-K">[http://www.sec.gov/Archives/edgar/data/318771/000031877107000004/form10-k_2006.htm], Genentech 2006 10-K.</ref><ref name="Pfizer 2006 10-K">[http://www.sec.gov/Archives/edgar/data/78003/000093041307001807/c46660_ex13.htm], Pfizer 2006 10-K.</ref><ref name="Eli Lilly & Co. 2006 10-K">[http://www.sec.gov/Archives/edgar/data/59478/000095013707003013/c12621e10vk.htm], Eli Lilly & Co. 2006 10-K.</ref><ref name="Allergan 2006 10-K">[http://www.sec.gov/Archives/edgar/data/850693/000095013707003060/a27376e10vk.htm], Allergan 2006 10-K.</ref><ref name="Merck 2006 10-K">[http://www.sec.gov/Archives/edgar/data/64978/000095012307002918/y30486e10vk.htm], Merck 2006 10-K.</ref><ref name="Ista Pharmaceuticals 2006 10-K">[http://www.sec.gov/Archives/edgar/data/930553/000119312506045920/d10k.htm], Ista Pharmaceuticals 2006 10-K.</ref>
!2005<ref name="Genentech 2005 10-K">[http://www.sec.gov/Archives/edgar/data/318771/000031877106000005/form10-k.htm], Genentech 2005 10-K.</ref><ref name="Pfizer 2005 10-K">[http://www.sec.gov/Archives/edgar/data/78003/000093041306001567/c40966_ex13.htm], Pfizer 2005 10-K.</ref><ref name="Eli Lilly & Co. 2005 10-K">[http://www.sec.gov/Archives/edgar/data/59478/000095013706002395/c02657e10vk.htm], Eli Lilly & Co. 2005 10-K.</ref><ref name="Allergan 2005 10-K">[http://www.sec.gov/Archives/edgar/data/850693/000089256906000217/a17071e10vk.htm], Allergan 2005 10-K.</ref><ref name="Merck 2005 10-K">[http://www.sec.gov/Archives/edgar/data/64978/000095012306003031/y18212e10vk.htm], Merck 2005 10-K.</ref>
!2004<ref name="Genentech 2004 10-K">[http://www.sec.gov/Archives/edgar/data/318771/000031877105000003/dna-10k_2004.htm], Genentech 2004 10-K.</ref><ref name="Pfizer 2004 10-K">[http://www.sec.gov/Archives/edgar/data/78003/000095012305002379/y06124exv13.htm], Pfizer 2004 10-K.</ref><ref name="Eli Lilly & Co. 2004 10-K">[http://www.sec.gov/Archives/edgar/data/59478/000095013405004385/c92539exv13.htm], Eli Lilly & Co. 2004 10-K.</ref><ref name="Allergan 2004 10-K">[http://www.sec.gov/Archives/edgar/data/850693/000095013705002808/a05924e10vk.htm], Allergan 2004 10-K.</ref>
!2003<ref name="Genentech 2003 10-K">[http://www.sec.gov/Archives/edgar/data/318771/000031877104000002/dna-10k_2003.htm], Genentech 2003 10-K.</ref><ref name="Pfizer 2003 10-K">[http://www.sec.gov/Archives/edgar/data/78003/000095012304003064/y94722exv13.htm], Pfizer 2003 10-K.</ref><ref name="Eli Lilly & Co. 2003 10-K">[http://www.sec.gov/Archives/edgar/data/59478/000095013704001857/c83409exv13.htm], Eli Lilly & Co. 2003 10-K.</ref><ref name="Allergan 2003 10-K">[http://www.sec.gov/Archives/edgar/data/850693/000089256904000307/a96815e10vk.htm], Allergan 2003 10-K.</ref>
!2002<ref name="Genentech 2002 10-K">[http://www.sec.gov/Archives/edgar/data/318771/000031877103000002/dna-10k_2002.htm], Genentech 2002 10-K.</ref><ref name="Pfizer 2002 10-K">[http://www.sec.gov/Archives/edgar/data/78003/000095012303003360/y83976exv13.htm], Pfizer 2002 10-K.</ref><ref name="Eli Lilly & Co. 2002 10-K">[http://www.sec.gov/Archives/edgar/data/59478/000095013703001575/c75275exv13.htm], Eli Lilly & Co. 2002 10-K.</ref><ref name="Allergan 2002 10-K">[http://www.sec.gov/Archives/edgar/data/850693/000089256903000654/a87937e10vk.htm], Allergan 2002 10-K.</ref>
!2001<ref name="Pfizer 2001 10-K">[http://www.sec.gov/Archives/edgar/data/78003/000095012302003116/y58494ex13.htm], Pfizer 2001 10-K.</ref>
!2000<ref name="Genentech 2000 10-K">[http://www.sec.gov/Archives/edgar/data/318771/000031877101500003/form10_k.txt], Genentech 2000 10-K.</ref><ref name="Eli Lilly & Co. 2000 10-K">[http://www.sec.gov/Archives/edgar/data/59478/000095013101001634/0000950131-01-001634-0005.txt], Eli Lilly & Co. 2000 10-K.</ref>
|-
|[[atorvastatin]]
|[[Lipitor]]
|Reduction of LDL cholesterol
|[[Pfizer]]
|$12,401
|$12,675
|$12,886
|$12,187
|$10,862
|$9,231
|$7,972
|$6,448
|$5,028
|-
|[[sunitinib malate]]
|Sutent
|Advanced and/or metastatic renal cell carcinoma (mRCC) & refractory gastrointestinal stromal tumors (GIST)
|[[Pfizer]]
|$847
|$581
|$219
|
|
|
|
|
|
|-
|[[irinotecan]]
|Camptosar
|Metastatic colorectal cancer
|[[Pfizer]]
|$563
|$969
|$903
|$910
|$554
|$299
|
|
|
|-
|[[bimatoprost]]
|Lumigan
|Open-angle glaucoma or ocular hypertension
|[[Allergan]]
|$426.2
|$391.7
|$327.5
|$267.6
|$232.9
|$181.3
|$123
|$35.4
|
|-
|[[exemestane]]
|Aromasin
|Breast cancer
|[[Pfizer]]
|$465
|$401
|$320
|$247
|$143
|$58
|
|
|
|-
|[[epirubicin]]
|Ellence
|Breast cancer
|[[Pfizer]]
|
|
|$312
|$367
|$344
|$216
|
|
|
|-
|[[trastuzumab]]
|Herceptin
|HER2-positive metastatic breast cancer
|[[Genentech]]
|$1,382
|$1,287
|$1,234
|$747.2
|$483.2
|$424.8
|$385.2
|$346.7
|$276
|-
|[[gemcitabine]]
|Gemzar
|Ovarian cancer, non-small cell lung cancer (NSCLC), metastatic breast cancer (MBC), and pancreatic cancer
|[[Eli Lilly & Co.]]
|$1,719.8
|$1,592.4
|$1,408.1
|$1,334.5
|$1,214.4
|$1,021.7
|$875
|$723
|$559.3
|-
|[[bevacizumab]]
|Avastin
|Metastatic colorectal cancer, non-small cell lung cancer (NSCLC), renal cell carcinoma, HER2-negative breast cancer
|[[Genentech]]
|$2,686
|$2,296
|$1,746
|$1,132
|$554.6
|
|
|
|
|-
|[[erlotinib]]
|Tarceva
|Advanced (metastatic) non-small cell lung cancer (NSCLC)
|[[Genentech]]
|$457
|$417
|$402
|$274.9
|$13.3
|
|
|
|
|-
|[[brimonidine]]
|Alphagan
|Open-angle glaucoma or ocular hypertension
|[[Allergan]]
|
|
|
|
|
|$286.8
|$248.5
|$250.9
|
|-
|[[rituximab]]
|Rituxan
|Non-Hodgkin's lymphoma and rheumatoid arthritis
|[[Genentech]]
|$2,587
|$2,285
|$2,071
|$1,831.4
|$1,574
|$1,360.2
|$1,162.9
|$818.6
|
|-
|[[ranibizumab]]
|Lucentis
|Age-related macular degeneration (AMD)
|[[Genentech]]
|$875
|$815
|$380
|
|
|
|
|
|
|-
|[[omalizumab]]
|Xolair
|Asthma
|[[Genentech]]
|$517
|$472
|$425
|$320.6
|$187.6
|$25.1
|
|
|
|-
|[[somatropin]]
|Nutropin
|Growth hormone deficiency, chronic renal insufficiency
|[[Genentech]]
|$358
|$371
|$378
|$370.5
|$348.8
|$319.5
|
|
|
|-
|[[dornase alfa]]
|Pulmozyme
|Cystic fibrosis (CF)
|[[Genentech]]
|$257
|$223
|$199
|$186.5
|$157.1
|$143.7
|$138.1
|$123
|
|-
|[[efalizumab]]
|Raptiva
|Plaque psoriasis
|[[Genentech]]
|$108
|$107
|$90
|$79.2
|$52.4
|$1.4
|
|
|
|-
|[[montelukast]]
|Singulair
|Asthma
|[[Merck & Co.|Merck]]
|$4,336.9
|$4,266.3
|$3,579
|$2,975.6
|$2,622
|
|
|
|
|-
|[[alendronate sodium]]
|Fosamax
|Postmenopausal osteoporosis
|[[Merck & Co.|Merck]]
|$1,552.7
|$3,049
|$3,134.4
|$3,191.2
|$3,159.7
|
|
|
|
|-
|[[sitagliptin]]
|Januvia
|Type 2 diabetes
|[[Merck & Co.|Merck]]
|$1,397.1
|$667.5
|$42.9
|
|
|
|
|
|
|-
|[[simvastatin]]
|Zocor
|Reduction of LDL cholesterol
|[[Merck & Co.|Merck]]
|$660.1
|$876.5
|$2,802.7
|$4,381.7
|$5,196.5
|
|
|
|
|-
|[[rizatriptan benzoate]]
|Maxalt
|Migraine pain
|[[Merck & Co.|Merck]]
|$529.2
|$467.3
|$406.4
|$348.4
|$309.9
|
|
|
|
|-
|[[finasteride]]
|Propecia
|Hair loss
|[[Merck & Co.|Merck]]
|$429.1
|$405.4
|$351.8
|$291.9
|$270.2
|
|
|
|
|-
|[[etoricoxib]]
|Arcoxia
|Osteoarthritis and rheumatoid arthritis
|[[Merck & Co.|Merck]]
|$377.3
|$329.1
|$265.4
|$218.2
|
|
|
|
|
|-
|[[sitagliptin]]/[[metformin]] HCl
|Janumet
|Type 2 diabetes
|[[Merck & Co.|Merck]]
|$351.1
|$86.4
|
|
|
|
|
|
|
|-
|[[finasteride]]
|Proscar
|Benign prostatic hyperplasia (enlarged prostate)
|[[Merck & Co.|Merck]]
|$323.5
|$411
|$618.5
|$741.4
|$733.1
|
|
|
|
|-
|[[aprepitant]]
|Emend
|Nausea and vomiting prevention caused by chemotherapy
|[[Merck & Co.|Merck]]
|$263.8
|$204.2
|$130.8
|$87
|
|
|
|
|
|-
|[[olanzapine]]
|Zyprexa
|Schizophrenia
|[[Eli Lilly & Co.]]
|$4,696.1
|$4,761
|$4,363.6
|$4,202.3
|$4,419.8
|$4,276.9
|$3,689
|$3,087
|$2,349.5
|-
|[[duloxetine]] HCl
|Cymbalta
|Depression and generalized anxiety disorder
|[[Eli Lilly & Co.]]
|$2,697.1
|$2,102.9
|$1,316.4
|$679.7
|$93.9
|
|
|
|
|-
|[[insulin lispro]]
|Humalog
|Type 1 diabetes in adults
|[[Eli Lilly & Co.]]
|$1,735.8
|$1,474.6
|$1,299.5
|$1,197.7
|$1,101.6
|$1,021.3
|$834
|$628
|$350.2
|-
|[[pemetrexed]]
|Alimta
|Locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC)
|[[Eli Lilly & Co.]]
|$1,154.7
|$854
|$611.8
|$463.2
|$142.6
|
|
|
|
|-
|[[raloxifene]] HCl
|Evista
|Osteoporosis
|[[Eli Lilly & Co.]]
|$1,075.6
|$1,090.7
|$1,045.3
|$1,036.1
|$1,012.7
|$922.1
|$822
|$665
|$521.5
|-
|[[insulin]] isophane
|Humulin
|Diabetes
|[[Eli Lilly & Co.]]
|$1,063.2
|$985.2
|$925.3
|$1,004.7
|$997.7
|$1,060.4
|$1,004
|$1,061
|$1,114.5
|-
|[[teriparatide]]
|Forteo
|Osteoporosis
|[[Eli Lilly & Co.]]
|$778.7
|$709.3
|$594.3
|$389.3
|$238.6
|$65.3
|
|
|
|-
|[[atomoxetine]] HCl
|Strattera
|Attention-deficit/hyperactivity disorder (ADHD)
|[[Eli Lilly & Co.]]
|$579.5
|$569.4
|$579
|$552.1
|$666.7
|$370.3
|
|
|
|-
|[[timolol]] 
|Istalol
|Open-angle glaucoma
|Ista Pharmaceuticals
|$14.6
|$11.3
|$8.3
|$2.6
|
|
|
|
|
|-
|[[bromfenac]] 
|Xibrom
|Ocular inflammation
|Ista Pharmaceuticals
|$63
|$42.1
|$20.2
|$5.3
|
|
|
|
|
|-
|[[hyaluronidase]] 
|Vitrase
|Spreading agent
|Ista Pharmaceuticals
|$5.2
|$5.2
|$4.2
|$2.5
|
|
|
|
|
|-
|}

==Notes==
{{reflist|2}}

[[Category:Drugs]]
[[Category:2Fix]]